Violet Therapeutics

Developer of small molecule therapeutics targeting neurodegenerative diseases of the CNS

placeCambridge, Massachusetts, United States calendar_todayFounded 2021 language violettx.com

Social engagement

Social engagement: 874 social following, 9 posts in the last 12 months — below the industry typical range.

Recent activity

22 Jan 2026
Event
ADPD
12 Nov 2025
Event
SfN2025
31 Jul 2025
Product launch
EphB3 inhibitor for Alzheimer's disease
Coming soon